Real-world experience with anti-ANGPTL3 antibody therapy in adult and adolescent patients with homozygous familial hypercholesterolaemia
Real-world experience with anti-ANGPTL3 antibody therapy in adolescent patients with homzygous familial hypercholesterolaemia
Panel Discussion: Latest developments and real-world experience in the management of homozygous familial hypercholesterolaemia
Therapeutic strategies for homozygous familial hypercholesterolaemia: a review of the clinical trial data